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Abstract 
Zinc phosphate particles were prepared by reaction of zinc nitrate with hydrogen phosphate, diphosphate and 
triphosphate, and characterized by Dynamic Light scattering (DLS) and Scanning Electron Microscopy (SEM). 
Antibacterial effect of ZnO nanoparticles and zinc phosphates ones were compared. Bacterial strains 
of (Escherichia coli NCTC 13216, Staphylococcus aureus NCTC 8511, and Methicillin-resistant S. aureus 
CCM 7110 were used for the testing. Oxidative stress was determined the GSH/GSSG ratio by using High-
pressure liquid chromatography with twelve-channel CoulArray electrochemical detector (HPLC-ED). It has 
been demonstrated the zinc phosphate particles shown better antibacterial properties and smaller toxicity, 
than the conventional ZnO. 
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1. INTRODUCTION 
Zinc is major element, which a responsible for physiological function in the body of animals or human, such as 
reproduction [1], replication and transcription [2], immune system, protection from bacterial endotoxins and 
antibody production [3]. On the other hand, Zn treatment of antibacterial activity have positive results in the 
concentration (2000 - 2500 mg/kg ) during 14 days and these high doses, however, carry a high risk of large 
amounts of zinc in the food chain [4]. Alternative forms of Zn, such as ZnO, Zn phosphate or ZnS have a best 
potential and widely used in agriculture in the form of animal feed supplement [5], biomedical applications, due 
to their low toxicity and biodegradability [6]. Nowadays, Zn nanoparticles may be used how alternative as 
antibiotics for animals, due as their antibacterial properties [7]. Aim of our study was to prepared of Zn NPs 
and their applications on Escherichia coli NCTC 13216, Staphylococcus aureus NCTC 8511, and Methicillin-
resistant S. aureus CCM 7110. Morphology of Zn nanoparticles were characterized by scanning electron 
microscope.  
2. METHODOLOGICAL BASES AND EXPERIMENTAL PART 
2.1. Chemicals 
Zinc nitrate. (NH4)2HPO4, Na2HPO4, Na4P2O7, Na5P3O10, GSH, GSSG, ZnO, methanol, trifluoroacetic acid 
were obtained from Sigma Aldrich (St. Louis, Missouri, USA).   
2.2. Determination of reduced and oxidised glutathione and selenium 
Reduced and oxidised glutathiones were determined using HPLC-ED. Experimental conditions were adopted 
from [8]. 




2.3. Dynamic light scattering and Scanning electron microscopic (SEM) characterization of Zn NPs 
The average particle size and size distribution were determined by quasielastic laser light scattering with a 
Malvern Zetasizer (NANO-ZS, Malvern Instruments Ltd., Worcestershire, UK). Structures of particles were 
characterized by electron microscope MIRA 3 XMU (Tescan, a.s., Brno, Czech Republic). The SEM was fitted 
with Everhart-Thronley type of SE detector, high speed YAG scintillator based BSE detector, panchromatic CL 
Detector. For automated acquisition of selected areas, a TESCAN proprietary software tool called Image 
Snapper was used.  
2.4. Powder X-ray analysis 
Powder X-ray analysis of Zn NPs was carried out on D8 Advance ECO (Bruker, AXS GmbH, Karlsruhe, 
Germany). Bragg-Brentano geometry, CuKα radiation (λ = 1.54178 Å), the range of 2θ = 4-60° and room 
temperature were used. 
2.5. Preparation of microparticles   
Zn-A. Zinc nitrate dissolved in water was heated to 60 °C and (NH4)2HPO4 was added with stirring. White 
precipitate was formed.  
Zn-B. Zinc phosphate was prepared similarly, only Na2HPO4 was used instead of ammonium salt.  
Zn-C. Solution of Na4P2O7 was added to stirred solution of zinc nitrate. White precipitate was obtained, filtered 
and dried.  
Zn-D. Zinc nitrate was mixed with Na5P3O10 solution. White precipitate was immediately formed. The 
suspension was filtered and product dried. 
Zn-AC. Zinc nitrate dissolved in water was heated to 60 °C and solution of citric acid and (NH4)2HPO4 was 
added with stirring. White precipitate was formed.  
2.6. Determination of antibacterial properties by method of growth curves 
The method is based on measuring of the absorbance using the apparatus Multiskan EX (Thermo Fisher 
Scientific, Germany) and subsequent analysis in the form of growth curves. Bacteria were cultivated in GTY 
medium for 24 h with shaking and were diluted with GTY medium using Specord spectrophotometer 210 
(Analytik, Jena, Germany) at a wavelength of 600 nm to absorbance 0.1. On the microplate, these cultures 
were mixed with various concentrations of NPs and a control. 
3. RESULTS AND DISCUSSION 
Aim of our study was preparation of zinc phosphates under different reaction conditions and their physico-
chemical study. For preparation of zinc phosphate sodium as well as ammonium salt were used. From powder 
XRD it follows that using ammonium salt only hopeite Zn3(PO4)2·4H2O was obtained (see Figure 1). When 
sodium salt was used under the same conditions than 90 % of product is hopeite but 10 % is zinc phosphate 
dehydrate. For Zn-C preparation diphosphate was applied and product was identified as Zn2P2O7·5H2O. More 
complicated situation is for Zn-D. XRD analysis shows on a mixture of three products. The most abundant 
component (60 %) was as expected zinc triphosphate Zn2HP3O10·6H2O but there is 30 % of Zn2P2O7·5H2O 
and 10 % of ZnHPO4·3H2O. We have also tried addition of citric acid to the reaction mixtures. For the product 
Zn-AC Zn3(PO4)2·4H2O, Zn3(PO4)2·4H2O and ZnHPO4·H2O (89, 8 and 3 %) were obtained. Addition of citric 
acid (Zn-DC) to reaction mixture containing triphosphate leads to nearly complete decomposition 
of triphosphate and Zn2P2O7·5H2O (97 %) with only minor part of Zn2HP3O10·6H2O resulted.  





Figure 1 XRD spectra of Zn-A (upper part) and Zn-C. (CPS = counts per second) 
DLS analysis of obtained materials show on particles in the range of 50 - 520 nm as well as some particles 
are much bigger probably due to the formation of aggregates. The size and shape were confirmed by SEM 
analysis (see Figure 2). For comparison zinc oxide nanoparticles and Zn-D are presented. ZnA and ZnB 
particles had spherical shape with the average diameter 477 and 520 nm, whereas ZnC formed small 
aggregates with average diameter 452 nm. Zn-D nanoparticles are comparable with those of ZnO 
nanoparticles with diameters from 50 to 100 nm. It can be clearly seen that nanoparticles were formed as well 
as their crystalline nature that was also proved by XRD analysis.   
 
Figure 2 SEM micrographs of ZnO-N (A) and Zn-D (B)   
The antibacterial activity of ZnNPs, ZnO and ZnO-N after 24 h was confirmed by the method of the growth 
curves. For the comparison ZnO particles and nanoparticles were used. From the growth curves inhibition 
curves (Figure 3) were obtained showing on either similar or better antibacterial properties of prepared zinc 
phosphates. From the literature, it is known that mostly higher antibacterial properties can be expected for 
lower sized nanoparticles and the activity depends on shape and solubility of nanoparticles. Interestingly, it 
was found for E. coli that with higher concentrations of nanoparticles inhibition of bacteria is lower. It can be 




explained by recovery of bacteria or by aggregation of nanoparticles in solution leading to lower active surface 
for interaction with microbial cell. Thus, better activity against E. coli show zinc phosphates Zn-A and Zn-B. 
 
Figure 3 Inhibition curves obtained for (A) E. coli, (B) S. aureus and (C) MRSA obtained under different 
concentrations of zinc phosphates (Zn-A, Zn-B, Zn-C, Zn-D) and zinc oxides (ZnO, ZnO-N) 
Levels of GSH were obtained by analysis of blood, kidney and liver samples of Laboratory male rats of the 
outbreed strain Wistar albino were selected as model animals. The rats were divided into four groups of ten 
rats each by phosphates or zinc oxides. Four groups of rats were fed with phosphate-based zinc nanoparticles 
(ZnA, ZnB, ZnC, ZnD) in the dose of 2000 mg Zn/kg diet. All groups of rats had monodiet including 2.7 mg/kg 
of zinc. The experiment duration was 28 days. The animals had access to feed and drinking water ad libitum. 
From animals were putted to death the blood, kidney and liver samples were collected for subsequent analyses 
of GSH and GSSG using HPLC-ED. The levels were related to total protein concentration. From the data it 
was apparent that GSH concentration significantly increases up to concentration 13 ±2 nmol GSH/g protein 
after zinc treatment in liver. The applied zinc nanoparticles have different effects on the GSH levels in the 
blood and kidneys and values of GSH are usually slightly higher in comparison with control. In the case 
of GSSG no significant difference between the different types of zinc phosphate nanoparticles was observed. 
 
Figure 4 Levels of GSH on blood, liver and kidney. Results are related to the total protein content. 
3. CONCLUSION 
In this study, zinc phosphate particles were prepared and characterized by SEM and powder X-ray analysis. 
The particles were tested for their antibacterial properties and it was found that they inhibit grow of bacteria 




better than zinc oxide which is usually used in veterinary practice. Lowering of zinc content is promising for 
application in agriculture.  
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